
Microsaic Systems plc, established in 1998 with its headquarters in Woking, UK, focuses on the creation, advancement, and worldwide marketing of compact mass spectrometry (MS) instruments. The company operates globally, with a presence across the United Kingdom, Japan, the United States, Europe, China, South Korea, and other international markets. It provides portable analytical solutions designed for real-time monitoring across diverse sectors, including water management, pharmaceuticals, chemical manufacturing, academic research, and the food and beverage industry. Its product range includes the MiD platform for MS detection, such as the 4500 MiD; the MiDas Automated Sampling interface, which streamlines direct MS analysis through automated sample handling; and the MiD Protein ID, another miniaturized mass spectrometer. Additionally, Microsaic Systems supplies vital consumables and spare parts for its systems. These innovations are crucial for applications in the pharmaceutical and biopharmaceutical fields, food safety, environmental analysis, and clinical diagnostics. The company further extends its services through comprehensive support and training programs, distributing its products via original equipment manufacturers (OEMs) and a network of distributors.
Microsaic Systems plc trades as MSYS.L on LSE. The company is classified in Technology / Hardware, Equipment & Parts and reports in GBP.
The current profile places the business in Hardware, Equipment & Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows £492,000 of revenue and -£2.60M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Microsaic Systems plc can be compared against peers such as Actual Experience plc, Crossword Cybersecurity Plc, Cloudfield Holdings Limited, LoopUp Group plc, Mobile Tornado Group plc, R8 Capital Investments plc.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £1.48M, beta of 0.27, and return on equity of -1803.5%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
MSYS.L currently shows total debt of £21,000 and beta of 0.27. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.microsaic.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.